Detailed View
INDP - Indaptus Therapeutics, Inc.
Latest filing: 2026-06-30 | Reporting: gaap
Market Cap
531,636,864
Adj EBIT (TTM)
-14,772,645
Enterprise Value
520,093,044
Last Price
3.99
Earnings Yield
-2.84%
Return on Capital
-123.23%
Capital
11,987,956
1Y Price Chart
Last Price: -
1Y Change: -
Company Summary
Loading summary...
| endDate | formType | fiscalYear | Revenue | OperatingIncomeLoss |
|---|---|---|---|---|
| 2026-06-30 | 10-Q | 2026 | 0 | -1,808,866 |
| 2026-03-31 | 10-Q | 2026 | 0 | -2,159,588 |
| 2025-12-31 | 10-K (Q4 derived) | 2025 | 0 | -8,155,704 |
| 2025-09-30 | 10-Q | 2025 | 0 | -2,648,487 |
| 2025-06-30 | 10-Q | 2025 | 0 | -4,456,763 |
| 2025-03-31 | 10-Q | 2025 | 0 | -4,572,559 |
| 2024-12-31 | 10-K (Q4 derived) | 2024 | 0 | -4,171,570 |
| 2024-09-30 | 10-Q | 2024 | 0 | -3,142,057 |
Notice something wrong?
Submit a quick report with a snapshot of the values you are seeing.